Cipla Limited (BOM:500087)
India
· Delayed Price · Currency is INR 1,317.15
+22.40 (1.73%)
At close: Apr 27, 2026
Cipla Employees
Cipla had 30,313 employees as of March 31, 2025. The number of employees increased by 2,549 or 9.18% compared to the previous year.
Employees
30,313
Change (1Y)
2,549
Growth (1Y)
9.18%
Revenue / Employee
9.23M INR
Profits / Employee
1.50M INR
Market Cap
1,055.37B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lupin | 24,006 |
| Dr. Reddy's Laboratories | 27,811 |
| Torrent Pharmaceuticals | 17,059 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| AstraZeneca Pharma India | 600 |
| Granules India | 4,066 |
Cipla News
- 1 day ago - Cohance Lifesciences Hits 20% Upper Circuit After Appointing Former Cipla CEO Umang Vohra as Chairman and Group CEO - Business Upturn
- 4 days ago - Cipla faces $100 million revenue risk as USFDA alert delays restart beyond FY27, says Macquarie - Business Upturn
- 4 days ago - Cipla Shares Fall 3% as Partner Unit Gets FDA Import Alert, Lanreotide Revenue at Risk - Business Upturn
- 4 days ago - Broker Calls Today: Infosys Gets Mixed Bag, Dr Reddy's Downgraded, Cipla Bullish on Ventolin Approval — Full Analyst Roundup - Business Upturn
- 5 days ago - Nifty 50 top gainers today, April 23: Dr. Reddy's Laboratories, Cipla, Jio Financial Services, Adani Enterprises and more - Business Upturn
- 5 days ago - Cipla gets USFDA nod for first AB-rated generic of Ventolin HFA - Business Upturn
- 5 days ago - Cipla receives USFDA approval for first AB-rated generic of Ventolin HFA - Business Upturn
- 6 days ago - Pharma sector stocks today, April 22: Natco Pharma up 1.4%, Lupin falls 1.01%, Cipla down 0.73% - Business Upturn